Open AccessSUN-113 COMBINATION OF *1/*1 WILD VARIANT OF CYP3A5 AND TT/AA MUTANT OF MDR G2677T/A GENE POLYMORPHISM REQUIRES HIGHER TACROLIMUS DOSE TO ACHIEVE TARGET TROUGH LEVEL
Author(s) -
Narayan Prasad,
Akhilesh Jaiswal,
Vikas Agarwal
Publication year - 2019
Publication title -
kidney international reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.225
H-Index - 22
ISSN - 2468-0249
DOI - 10.1016/j.ekir.2019.05.511
Subject(s) - tacrolimus , efflux , bioavailability , pharmacokinetics , medicine , pharmacology , mutant , transplantation , slco1b1 , therapeutic index , cyp3a5 , gene , pharmacogenetics , drug , biology , genotype , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom